ADIPOQ and atherosclerosis: They activate the ubiquitin pathway, inhibit the activation of AMP-activated protein kinase (AMPK) and adiponectin, and reduce the activity of endothelial nitric oxide synthase (eNOS), all of which accelerate the development of atherosclerosis, leading to the progression of diabetic vascular complications.